CompletedNCT01809158
Minocycline Compared With Placebo for Schizophrenia
Medication studyAges 18–64Ethiopia
Understand this study
Who was this study for?
Listed age limits: 18 years to 64 years.
- Listed locations
- Addis AbabaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 150
- Sponsor
- Addis Ababa University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Ethiopia
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT01809158
- Official title
Show the full official title
A Double-blind Randomized Placebo-controlled Trial of Adjuvant Therapy With Minocycline for Schizophrenia
Get this study by email
Recruitment & locations
CompletedAddis Ababa
Questions about this study
Who is behind this study?
The study sponsor is Addis Ababa University, a university.
Did this study involve medication?
Yes. The study involved medication, including minocycline and placebo.
Who was this study for?
Listed age limits: 18 years to 64 years.
